口服L-苏糖酸镁通过正常化TNF-α/NF-κB信号减轻长春新碱诱导的痛敏
本研究在成年雄性Sprague-Dawley大鼠中,用长春新碱(0.1 mg·kg·day腹腔注射10天)诱导痛觉敏化,发现其激活TNF-α/NF-κB信号并降低脑脊液和背根神经节神经元游离镁,口服L-苏糖酸镁(604 mg·kg·day)可预防镁缺乏并减轻痛敏和信号激活。
要点
- 长春新碱诱导痛敏伴脑脊液游离镁降低21.7±6.3%、背根神经节神经元降低27±6%。
- 口服L-苏糖酸镁(604 mg·kg·day)预防镁缺乏并减轻痛敏和TNF-α/NF-κB激活。
- 机制涉及C纤维突触长时程增强、NMDA受体2B亚基上调及肽能C纤维出芽。
核心结论
- 长春新碱可能通过降低细胞内镁激活TNF-α/NF-κB通路,导致脊髓病理可塑性和痛觉敏化。
- 口服L-苏糖酸镁预防镁缺乏,是预防化疗诱导神经病理性疼痛的新方法。
研究设计与样本
- 成年雄性Sprague-Dawley大鼠,长春新碱0.1 mg·kg·day腹腔注射10天诱导痛觉敏化,von Frey纤维和足底测试仪评估。
- L-苏糖酸镁经饮水给药604 mg·kg·day,采用Calmagite比色法和流式细胞术测镁,并行分子生物学和电生理实验。
主要发现
- 长春新碱注射诱导痛敏(n=12),激活TNF-α/NF-κB信号,脑脊液游离镁降低21.7±6.3%(n=13),背根神经节神经元降低27±6%(n=11)。
- 降低镁在培养背根神经节神经元中激活TNF-α/NF-κB信号。
- 口服L-苏糖酸镁预防镁缺乏并减轻TNF-α/NF-κB信号激活和痛觉敏化(n=12)。
- 长春新碱诱导C纤维突触长时程增强、NMDA受体2B亚基上调及脊髓背角肽能C纤维出芽(各n=6),鞘内注射NF-κB抑制剂阻断(n=6),TNF-α可模拟,口服L-苏糖酸镁显著预防(n=5)。
临床怎么用
- 口服L-苏糖酸镁可能作为预防化疗诱导神经病理性疼痛的新策略,尚需临床验证。
局限性
- 研究仅在大鼠中进行,样本量较小,临床转化需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antineoplastic agents, including vincristine, often induce neuropathic pain and magnesium deficiency clinically, but the causal link between them has not been determined. No drug is available for treating this form of neuropathic pain. METHODS: Injection of vincristine (0.1 mg · kg · day, intraperitoneally, for 10 days) was used to induce nociceptive sensitization, which was accessed with von Frey hairs and the plantar tester in adult male Sprague-Dawley rats. Magnesium-L- threonate was administered through drinking water (604 mg · kg · day). Extracellular and intracellular free Mg were measured by Calmagite chromometry and flow cytometry. Molecular biologic and electrophysiologic experiments were performed to expose the underlying mechanisms. RESULTS: Vincristine injection induced allodynia and hyperalgesia (n = 12), activated tumor necrosis factor-α/nuclear factor-κB signaling, and reduced free Mg in cerebrospinal fluid by 21.7 ± 6.3% (mean ± SD; n = 13) and in dorsal root ganglion neurons by 27 ± 6% (n = 11). Reducing Mg activated tumor necrosis factor-α/nuclear factor-κB signaling in cultured dorsal root ganglion neurons. Oral application of magnesium-L-threonate prevented magnesium deficiency and attenuated both activation of tumor necrosis factor-α/nuclear factor-κB signaling and nociceptive sensitization (n = 12). Mechanistically, vincristine induced long-term potentiation at C-fiber synapses, up-regulated N-methyl-D-aspartate receptor type 2B subunit of N-methyl-D-aspartate receptor, and led to peptidergic C-fiber sprouting in spinal dorsal horn (n = 6 each). The vincristine-induced pathologic plasticity was blocked by intrathecal injection of nuclear factor-κB inhibitor (n = 6), mimicked by tumor necrosis factor-α, and substantially prevented by oral magnesium-L-threonate (n = 5). CONCLUSIONS: Vincristine may activate tumor necrosis factor-α/nuclear factor-κB pathway by reduction of intracellular magnesium, leading to spinal pathologic plasticity and nociceptive sensitization. Oral magnesium-L-threonate that prevents the magnesium deficiency is a novel approach to prevent neuropathic pain induced by chemotherapy.
引用
- Xu T, Li D, Zhou X, et al. Oral Application of Magnesium-L-Threonate Attenuates Vincristine-induced Allodynia and Hyperalgesia by Normalization of Tumor Necrosis Factor-α/Nuclear Factor-κB Signaling. Anesthesiology. 2017. PMID: 28306698. doi:10.1097/ALN.0000000000001601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。